Thomas V.
de la Bastide III

Tom de la Bastide is a partner in the Corporate Department and the Global Co-Head of Finance. He specializes in financings for leveraged buyouts, alternative lending transactions for hedge funds, mezzanine funds, banks and other lenders, corporate debt issuances for Fortune 500 companies and complex debt restructurings. Tom has been consistently recognized for his work by leading publications, including *The Legal 500*, and is recognized as one of *Lawdragon*’s 500 Leading Dealmakers.

Working with clients across a broad spectrum of financing transactions, Tom represents major corporations, financial institutions, hedge funds and private equity sponsors in their acquisition financings, secured and unsecured bank financings, mezzanine financings, second-lien financings, asset-based loans, restructurings and DIP and exit facilities.

He advises clients in domestic and international lending transactions, including acquisitions, divestitures, structured financings, restructurings and derivative products. Tom also has significant experience in junior capital lending transactions, intercreditor issues and secured creditor and bankruptcy rights. His clients represent a variety of industries, including consumer products, manufacturing, media and entertainment, apparel, food and beverage, publishing, oil and gas, automotive and technology.

Tom’s public company representations include:

• Bioverativ in the financing aspects of its $11.6 billion acquisition by Sanofi
• Continental Grain in the M&A and financing aspects of its all-cash acquisition, alongside global food corporation Cargill, of Sanderson Farms Inc. representing a total equity value of $4.53 billion
• Conair in its sale to affiliates of American Securities, including the financing aspects of the transaction
• Dana Inc. in the $1.7 billion senior secured credit facilities in connection with its acquisition of the Drive Systems segment of the Oerlikon Group, as well as in the company’s $500 million bridge facility and additional $150 million revolving credit facilities
• Elanco Animal Health in the $5 billion senior secured credit facilities in connection with the acquisition of Bayer Animal Health
• Encana Corp. in the financing aspects of its $7.7 billion acquisition of Newfield Exploration Company
• Michael Kors in numerous transactions, including the financing aspects of its $1.35 billion acquisition of Jimmy Choo and over $1 billion in credit facilities
• Nellson Nutraceutical in an “amend & extend” transaction for its senior secured credit facilities
• Revlon in its $1.83 billion term loan financing, successful out-of-court exchange offer and multiple refinancings
• Virtu Financial in its $650 million senior secured term loan facility in connection with the refinancing of existing indebtedness
• Taylor Morrison Home Corp. in its $800 million senior secured credit facilities in connection with the refinancing of existing indebtedness

Tom’s private equity and funds representations include:

• Ares Management in numerous transactions, including multiple credit agreements, credit facilities and acquisition financings for companies including Bombardier Aerospace, Commercial Trailer Leasing, FTAI Infrastructure, Gamut Capital Management, Greenbrier Hotel, Infrastructure and Energy Alternatives, Insightful Science, Integrated Power Services, Savers Thrift Chain, STP Acquisition and Wastequip, among others
• The Carlyle Group in the financing aspect of its acquisition of Content Partners, and in Content Partners’ subsequent acquisition of a portfolio of interests in 200 films and several hundred episodes of television
• Kohlberg & Co. in numerous transactions, including its $1.2 billion credit facilities in connection with its acquisition of PCI Pharma; its $925 million credit facilities in connection with its acquisition of Parts Authority; its $756 million credit facilities in connection with SpecialtyCare’s refinancing; the financing in connection with the acquisition of Worldwide Clinical Trials; and the financing aspects of its acquisitions of DecoPac, Myers EPS and Ob Hospitalist Group, among others
• OceanSound Partners in the financing aspects of its acquisition of PAR Excellence from Northlane Capital Partners
• The Chatterjee Group in numerous transactions, including alongside private equity firm Rhone Group and Illuminate Buyer in connection with $1.3 billion in credit facilities to fund a portion of the acquisition of McDermott International Inc.’s Lummus Technology Group

Tom’s corporate reorganization and refinancing representations include:

• Charlesbank Capital Partners as arranger and lender under a $350 million first lien term loan facility with the parent company of FullBeauty. The facility will refinance and replace certain term loans incurred by FullBeauty upon its exit from its 2019 pre-arranged bankruptcy
• Rotech Healthcare in the financing aspects of its $625 million refinancing, consisting of a senior secured revolving credit facility and senior secured term loan, a portion of the proceeds of which were used to pay a special dividend to the indirect parent of the borrower
• TPG in the planned chapter 11 proceedings of its portfolio company, J.Crew Group, Inc. and in the restructuring proceedings of its portfolio company, Cirque du Soleil Entertainment Group
• Towerbrook Capital Partners in the successful out-of-court restructuring of its portfolio company J.Jill

Tom’s additional representative clients include Centerbridge Partners, GP Investments, KPS Capital Partners, Palladium Equity Partners, Pamplona Capital and Wellspring Capital Management.